What does it really take for a biotech company to become an attractive acquisition target?
In this episode of PharmaShots CXO Talks, Jared Kelly, CEO & Director of Oncolytics Biotech, shares an insider's perspective shaped by years of experience in biotech transactions, corporate strategy, and business development.
Before joining Oncolytics, Kelly served as Head of…
